March 15, 2018
by Andrii Buvailo
Biopharma insight
(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate …
March 8, 2018
by Andrii Buvailo
Biopharma insight
“One-target-one-disease” paradigm has been around for decades, prompting numerous drug discovery programs focusing on identifying small molecules for targeting only …
Feb. 15, 2018
by Peter Jarowski
Biopharma insight
In the domain of drug discovery, there can be a world of difference between a computer-generated hit compound, which is …
Jan. 18, 2018
by Andrii Buvailo
Interview
The previous year was rich in discussions and events one way or another related to potential applications of artificial intelligence …
Jan. 11, 2018
by Andrii Buvailo
Biopharma insight
With all the hot discussions (for instance, here, here, here and here) going on right now among medicinal chemists, pharmaceutical …
Jan. 2, 2018
by Alfred Ajami
Biopharma insight
Effective drug discovery begins with the right assay, but the definition of "right" will shift as technology advances. More often …
Dec. 26, 2017
by Andrii Buvailo
Interview
Without a doubt, the area of artificial intelligence (AI) has been a sensation lately -- judging by the amount of …
Nov. 22, 2017
by Alfred Ajami, Andrii Buvailo
Biopharma insight
Choosing the right biological target or a combination of targets is a fundamental task for any successful drug discovery project. …
Nov. 22, 2017
by Alfred Ajami
Biopharma insight
The question is often raised, but the answer remains to be uncovered because the definition of drug "target" continues to …
Nov. 13, 2017
by Alfred Ajami
Biopharma insight
Consensus seems universal and the news about it flows literally by the minute over gene editing as a future therapy, …
Nov. 6, 2017
by Alfred Ajami
Biopharma insight
Pharma productivity has remained a daunting challenge, notably because R&D departments have been shuffled and reorganized over the last few …
Oct. 27, 2017
by Alfred Ajami
Biopharma insight
In a case of "back to the future", chemists at Scripps collaborating with instrument engineers at IKA have unveiled a …